Animal testing requirements for monoclonal antibodies and other medications will be “reduced, refined or potentially replaced ...

The FDA is moving away from requiring animal models for investigational new drug (IND) applications for new monoclonal ...

This is a groundbreaking step toward advancing public health by using more effective and human-relevant methods instead of ...

Boster Bio Technology unlocks insights into cancer and neurological disorders with high-quality antibodies that offer exceptional specificity and sensitivity.

Ebdarokimab is the company's first Class 1 new drug approved for autoimmune diseases and the second non-oncology new drug to receive marketing approval, following ebronucimab (PCSK9). This approval ...

The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that ...

The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies ...

The U.S. Food and Drug Administration is replacing animal testing in the development of monoclonal antibody therapies and other drugs with ...